a public good project by the
Synthesis
Company
of California

© 2026

Hiroshi Maegawa | doi.page

0 works0 citations0 h-index

Hiroshi Maegawa

Publications by Year

Research Areas

Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Diabetes Management and Research, Adipose Tissue and Metabolism

Most-Cited Works

→ Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus(2008)768 cited
→ A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.(1987)405 cited
→ Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKB(2000)387 cited
→ SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition(2020)347 cited
→ Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy(2015)305 cited
→ Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial(2017)304 cited

→ A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B(2010)

269 cited

→ Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction.(1994)241 cited

→ Oral Administration of Tetrahydrobiopterin Prevents Endothelial Dysfunction and Vascular Oxidative Stress in the Aortas of Insulin-Resistant Rats(2000)240 cited

→ Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes(2004)236 cited